Astrana Health, Inc. ASTH
Nasdaq · XNAS · stock · Services-Management Consulting Services
Chart by TradingView
3/9
Piotroski F — financial health
1.92
Altman Z″ — distress risk · grey
35.1%
Dividend payout · safe
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $3.2B | $22.5M | — | $104.5M | $779.3M |
| 2024 | $2.0B | $43.1M | — | $44.2M | $716.7M |
| 2023 | $1.4B | $60.7M | — | $39.7M | $616.7M |
| 2022 | $1.1B | $45.2M | — | $59.2M | $544.3M |
| 2021 | $773.9M | $68.9M | — | $51.1M | $454.1M |
| 2020 | $687.2M | $37.9M | — | $45.0M | $329.5M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 1.92 (grey)
- Working capital / assets 0.112
- Retained earnings / assets 0.139
- EBIT / assets 0.035
- Equity / liabilities 0.469
Source: SEC EDGAR filings · CIK 0001083446 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.